NCT06517017 2025-11-28
UltraFrailMM
University of Utah
Phase 2 Recruiting
Clinical Trials
4 trialsNCT02547662 2023-10-30
Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia
Mayo Clinic
Phase 2 Completed
NCT01553357 2012-03-14
Lenalidomide and Dexamethasone in Primary Plasma Cell Leukemia
IRCCS Centro di Riferimento Oncologico della Basilicata
Phase 2 Completed
NCT01328236 2011-09-22
Bortezomib
Clinical Service, China
Phase 2 Unknown